Myriad Genetics board member steps down
(AP) — Molecular diagnostics company Myriad Genetics Inc. said Tuesday Dr. Mark Skolnick will step down from its board of directors.
Skolnick will remain with the company as a part-time employee in the capacity of senior scientist emeritus. He has served on the board since 1991.
On June 30, the company completed a spin-off of its former research and drug development businesses, which now make up a separate publicly traded company called Myriad Pharmaceuticals.
Out East Show: LI Aquarium, Patty's Berries and Bunches, Palmer Vineyards NewsdayTV's Doug Geed shows us some great spots 'Out East' to visit this summer.
Out East Show: LI Aquarium, Patty's Berries and Bunches, Palmer Vineyards NewsdayTV's Doug Geed shows us some great spots 'Out East' to visit this summer.
